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Objectives: The Cox maze procedure has been confirmed to be effective in
curing atrial fibrillation. Some authors have reported severe fluid retention
after the Cox maze procedure and have suggested decreased secretion of
atrial natriuretic peptide as a possible mechanism. This study was designed
(1) to examine the serial changes in atrial natriuretic peptide after the Cox
maze procedure as compared with changes occurring after coronary artery
bypass grafting and (2) to elucidate any differences in atrial natriuretic
peptide levels between patients with transient recurrence of atrial fibrilla-
tion after the Cox maze procedure and those without recurrence of atrial
fibrillation. Methods: Blood samples were drawn from the right and left
atria in patients undergoing the Cox maze procedure (n 5 19) and from the
right atrium in patients undergoing coronary artery bypass grafting (n 5 6)
before and 1, 2, and 3 days after the operation. In six patients undergoing
the Cox maze procedure, samples were also drawn from the radial artery
before and 1, 2, 3, 5, and 7 days after the operation. The plasma samples
were prepared by refrigerated centrifugation and stored until radioimmu-
noassay. In the Cox maze procedure group, atrial natriuretic peptide levels
in the right atrium were 629 6 366, 154 6 112, 162 6 112, and 183 6 97
pg/ml and those in the left atrium were 276 6 168, 152 6 91, 162 6 111, and
145 6 80 pg/ml before and 1, 2, and 3 days after the operation, respectively.
A marked decrease in atrial natriuretic peptide levels was evident after the
Cox maze procedure (p < 0.001). There was no significant correlation
between atrial natriuretic peptide levels and atrial pressures after the Cox
maze procedure, which suggests that secretion of atrial natriuretic peptide
by the atria was impaired. There was a significant correlation between the
atrial natriuretic peptide levels in the left atrium and those in the
peripheral radial artery, and the decreased levels of atrial natriuretic
peptide in the radial artery continued for 7 days after the Cox maze
procedure. There were no differences in the atrial natriuretic peptide levels
between the patients with transient recurrence of atrial fibrillation (n 5 6)
and those without recurrence (n 5 13) after the Cox maze procedure. In the
coronary artery bypass grafting group, the atrial natriuretic peptide levels
in the right atrium were 115 6 37, 124 6 48, 154 6 54, and 156 6 36 pg/ml
before and 1, 2, and 3 days after the operation, respectively. No change was
seen after the operation. Conclusions: We observed a significant decrease in
atrial natriuretic peptide levels after the Cox maze procedure. This may be
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one of the possible causes of fluid retention after this procedure. These
decreased atrial natriuretic peptide levels after the Cox maze procedure
may result from the multiple atriotomy incisions and excision of both atrial
auricles performed during the procedure, rather than from the conversion
of atrial fibrillation to normal sinus rhythm. (J Thorac Cardiovasc Surg
1998;115:139-47)
The Cox maze procedure (CMP), developed byCox and associates,1, 2 has become a safe and
efficient surgical treatment for medically refractory
atrial fibrillation (AF). It has been widely performed
as a concomitant procedure in patients with organic
cardiac diseases and chronic AF.3, 4 Despite the
beneficial midterm results of the CMP for AF,
postoperative fluid retention with pulmonary edema
and symptomatic pleural effusion has been observed
as one of the early postoperative complications in
12% to 36% of the patients.5, 6 Cox and associates1
suggested that this may be the result of a postoper-
ative decrease in the atrial natriuretic peptide
(ANP) level that is triggered by the multiple atri-
otomy incisions and the excision of both atrial
auricles that are performed during the CMP. How-
ever, few reports have demonstrated a decrease in
ANP levels after the CMP.
Several reports have shown a relationship be-
tween ANP levels and AF by demonstrating that
ANP levels decrease in response to the conversion
of AF to normal sinus rhythm.7-9 Therefore, there
are two possible explanations for the postoperative
decrease of ANP levels after the CMP, the surgical
incisions that include multiple atriotomies and exci-
sion of both atrial auricles and postoperative con-
version of AF to normal sinus rhythm. The aims of
this study were (1) to examine the serial changes in
ANP levels after the CMP and compare them with
those after coronary artery bypass grafting (CABG)
and (2) to elucidate any differences between ANP
levels in patients with transient recurrence of AF
after the CMP and those in patients without recur-
rence of AF.
Patients and methods
The CMP was performed in 19 patients with various
organic heart diseases combined with AF. Our indications
to perform the concomitant CMP were chronic AF,
presence of left atrial (LA) thrombus, or medical history
of previous thromboembolic events. There were 11 men
and 8 women, with a mean age of 46 6 8 years. The mean
duration of AF before the operation was 68 6 54 months
(4 to 180 months), and the mean size of the LA on
preoperative transthoracic echocardiography was 57 6 7
mm (37 to 70 mm). Most of the patients in the CMP group
had been treated before the operation with diuretics and
digitalis for congestive heart failure and AF. Eighteen
patients, all but the one patient with a ruptured sinus of
Valsalva, underwent mitral valve operations. Additional
concomitant procedures involved aortic valve operations
in nine patients, tricuspid valve surgery in four, closure of
atrial septal defect in two, and CABG in one. The CMP
III, as described elsewhere by Cox and coworkers,10 was
performed. After the CMP, six patients (32%) had tran-
sient recurrence of AF during the early postoperative
period. The recurrent AF continued from the operative
day until at least the third day after the operation, with
conversion to normal sinus rhythm some days later. For
comparison with the CMP group, seven patients with
ischemic heart disease who were undergoing CABG were
studied. These patients were all male, with a mean age of
54 6 8 years, and were in sinus rhythm before and after
the operation.
This study was approved by the hospital ethics commit-
tee. Written, informed consent was obtained from each
participating patient.
Measurement. In the CMP group, a median sternot-
omy was performed and the pericardium was opened
with the patient under general anesthesia. The pres-
sures were then measured in and blood samples were
obtained from both atria. Postoperative blood sampling
and pressure measurement of the right atrium (RA)
were carried out through a thermodilution catheter,
and those of the LA were performed through a pressure
line inserted in the right upper pulmonary vein. Post-
operative blood sampling and pressure measurements
were continued on the first, second, and third postop-
erative days. Blood samples were also obtained from
the radial artery on the first, second, third, fifth, and
seventh postoperative days in six cases among the CMP
group for comparison with the atrial samples and to
examine the serial changes after the operation. In the
CABG group, blood samples from the RA and RA
pressure measurements were obtained through a ther-
modilution catheter on the first, second, and third
postoperative days.
Specimens of blood from each atrium and the radial
artery (10 ml each) were collected into ethylenedi-
aminetetraacetic acid–treated tubes, stored in ice, and
immediately centrifuged at 3000 rpm for 10 minutes at
4° C to separate the plasma. The plasma samples were
preserved at –70° C until the assay.
ANP concentration was determined by radioimmuno-
assay with rabbit anti-ANP serum (K-625 Radioimmuno-
assay kit for Atrial Natriuretic Peptide; Research &
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Diagnostic Antibodies, Berkeley, Calif.). ANP levels were
measured twice for each sample, and a mean was calcu-
lated as a representative value.
Statistics. Statistical analysis was performed with the
Statistical Analysis System software package (version 6.04;
SAS Institute, Cary, N.C.). The significance of changes
was assessed by Student’s paired t test. Linear regression
analysis was used to determine any correlations between
the ANP levels in each atrium and independent hemody-
namic variables, and also between the ANP levels of both
atria and those of the radial artery. Repeated-measures
analysis of variance was also performed to investigate the
influence of postoperative recurrent AF on the ANP
levels. All results were expressed as mean 6 standard
deviation, and a value of p less than 0.05 was considered
statistically significant.
Results
CMP group. The ANP levels in the RA were
629 6 366, 154 6 112, 162 6 112, and 183 6 97
pg/ml and those in the LA were 276 6 168, 152 6
91, 162 6 111, and 145 6 80 pg/ml just after
induction of anesthesia and 1, 2, and 3 days after the
operation, respectively. There was a statistically
significant decrease in ANP levels in both atria after
the CMP (p , 0.001; Fig. 1). RA pressures were 8 6
4, 13 6 3, 15 6 3, and 17 6 4 mm Hg and LA
pressures were 18 6 9, 17 6 4, 18 6 4, and 21 6 4
mm Hg just after induction of anesthesia and 1, 2,
and 3 days after the operation, respectively. The LA
pressure was about two times higher than the RA
pressure before the operation; however, the preop-
erative ANP level was about two times higher in the
RA than in the LA. There was no significant corre-
lation between the preoperative ANP levels and
preoperative pressures in each atrium, or between
LA preoperative ANP levels and LA size as mea-
sured by preoperative transthoracic echocardiogra-
phy. Furthermore, there were no significant corre-
lations between the ANP levels and the pressures of
each atrium after the CMP.
In the six cases with radial arterial sampling, the
ANP levels were 488 6 315, 255 6 107, 256 6 119,
220 6 75, 248 6 98, and 212 6 99 pg/ml just after
induction of anesthesia and 1, 2, 3, 5, and 7 days
after the operation, respectively (Fig. 2). The
decreased ANP levels in the radial artery contin-
ued for 7 days after the operation. There was a
close correlation between the ANP levels of the
LA and those of the radial artery, with correlation
coefficients (r) of 0.83 (p 5 0.04), 0.77 (p 5 0.07),
0.60 (p 5 0.20), and 0.89 (p 5 0.01) just after
induction of anesthesia and 1, 2, and 3 days after
the operation, respectively.
There was a statistically significant decrease in the
ANP levels both in the patients with transient
recurrence of AF after the operation and in those
without recurrence of AF after the CMP (p ,
0.001). The postoperative ANP levels of the AF
recurrence group did not increase significantly de-
spite the AF, and there were no significant differ-
ences in the ANP levels between the groups with
time (Fig. 3).
CABG group. There were no episodes of AF
after the operation in this group, nor were there any
significant postoperative changes in RA pressure.
The ANP levels in the RA were 115 6 37, 124 6 48,
154 6 54, and 156 6 36 pg/ml just after induction of
anesthesia and 1, 2, and 3 days after the operation,
respectively; they showed no significant postopera-
tive change (Fig. 4).
Discussion
ANP, a 28-amino acid peptide synthesized and
secreted by the atria, has several biologic effects.
These include natriuresis and diuresis, vasodilation,
suppression of renin, and aldosterone secretion.11 A
decrease of ANP level has been suggested as a
possible mechanism that causes postoperative fluid
retention after the CMP.
This study reveals four main findings. First, the
ANP levels in both atria decrease significantly
after the CMP, and this may be one of the causes
of postoperative fluid retention. Second, there is
no significant correlation between the ANP levels
and pressures in each atrium after the CMP,
suggesting that the secretion of ANP from the
atria is impaired. Third, the decreased ANP levels
in the radial artery continue until the seventh
postoperative day, which suggests that the resto-
ration of atrial mechanical function is delayed at
least 1 week after the CMP. Fourth, there are no
differences in the ANP levels between patients
with transient recurrence of AF after the CMP
and those without recurrence; this suggests that
the decreased ANP levels after the CMP may
result from the multiple atriotomy incisions and
excision of both atrial auricles, rather than from
the conversion of AF to normal sinus rhythm.
ANP levels at different sites and the relationship
between the ANP levels and atrial pressures. Most
of our patients had mitral valvular disease, and the
LA pressure was about two times higher than the
RA pressure before the operation; however, the
preoperative ANP levels were about two times
higher in the RA than in the LA. A highly significant
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increase in ANP levels in the RA was also found in
a previous study, reflecting secretion of ANP into
the coronary sinus and extraction of ANP by the
lungs.12 Northridge and associates13 showed a
higher ANP level in the LA than in the pulmonary
veins and demonstrated secretion of the ANP into
the LA as well as the RA. Our study demonstrates
that there is a significant correlation between the
ANP levels of the LA and those of the radial artery,
and that the decreased levels of ANP continue until
the seventh postoperative day. This close relation-
ship between LA and radial artery levels of ANP
Fig. 1. Changes in atrial ANP levels and pressures in the CMP group. Statistically significant decreases in
ANP levels in both RA (A) and LA (B) were seen after the CMP (p , 0.001). RAANP, RA ANP levels;
RAP, RA pressure; Preop, just after induction of anesthesia; POD, postoperative day; LAANP, LA ANP
levels; LAP, LA pressure.
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was also found previously.12, 13 The radial artery
ANP levels are therefore indicative of those of the
central cardiac chambers.
The search for a mechanism that results in a
release of ANP from the atria has produced several
demonstrations of a relationship between atrial
pressures and plasma ANP levels.7, 14, 15 Another
study16 emphasized the role of the atrial stretch,
rather than atrial pressure, in the release of ANP.
Our study shows an insignificant correlation be-
tween ANP levels and atrial pressures in the CMP
group, suggesting that the secretion of ANP from
the atria was impaired.
Postoperative changes in ANP levels. Ashcroft
and associates17 demonstrated that the postopera-
tive ANP levels in their group of patients undergo-
ing valve replacement showed a smaller increase in
postoperative ANP response. They suggested that
those findings were the result of a combination of
atrial damage and reduced atrial pressure caused by
valve replacement or adaptation to chronic fluid
overload; thus the valve-replacement group might
have been more prone to fluid and salt retention.
Our study demonstrates a significant decrease in
postoperative ANP levels in comparison with the
preoperative ANP levels in both atria of the CMP
group. As suggested previously,1 this finding may be
the result of a postoperative decrease in the ANP
levels triggered by the multiple atriotomy incisions
and excision of both atrial auricles. In patients with
chronic AF, chronically elevated levels of ANP may
lead to a resetting of the specific renal receptors7;
the abrupt postoperative decrease of ANP levels
therefore has a high possibility of being the cause of
fluid retention. Cox and associates6 administered
spironolactone to all patients after the operation to
prevent postoperative fluid retention, and Perera
and associates18 suggested the use of ANP after the
CMP as a therapeutic possibility. The patients in our
study did not have any postoperative fluid retention
despite the significant decrease in ANP levels. We
believe this is related to preoperative treatment of
the patients with diuretics because of some degree
of congestive heart failure and postoperative treat-
ment with diuretics to maintain adequate urine
output. There were no significant changes in the
postoperative ANP levels in the CABG group. Fu-
jiwara and associates9 showed a gradual increase in
ANP levels in patients with AF from the fourth hour
to 5 days after cardioversion, concomitant with an
increase in atrial filling fraction. They suggested
recovery of atrial mechanical function as the mech-
anism. In our study, the ANP levels in the radial
artery remained decreased until the seventh postop-
Fig. 2. Changes in the ANP levels of the radial artery (ARTANP) in comparison with those of RA
(RAANP) and LA (LAANP) in the CMP group. ARTANP showed a close correlation with LAANP, and
the decreased ARTANP continued for 7 days after the CMP. Preop, just after induction of anesthesia;
POD, postoperative day.
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erative day. This suggests that atrial mechanical
function after the CMP may need more time to
recover.
Effect of recurrent AF on ANP levels. Roy and
associates7 demonstrated a decrease in ANP lev-
els in patients with chronic AF after restoration to
sinus rhythm and a significant increase in ANP
levels during laboratory-induced supraventricular
tachycardia. Dussaule and associates19 observed
decreases in ANP levels as well as in LA pressures
after percutaneous balloon valvuloplasty in pa-
tients with mitral stenosis without AF; however,
the plasma ANP levels remained elevated in
patients with AF despite the decrease in LA
pressure. They suggested that the inappropriate
response of ANP to the decrease in the LA
pressure was caused by the high firing rate of the
atria, abnormal stretch of the atrial wall, and
larger atrial volume. These observations imply
that recovery from the high firing rate of the atria
in AF may also be an important factor in the
decrease in ANP levels, in addition to the CMP’s
Fig. 3. Comparison of the RA (A) and LA (B) ANP levels between patients with recurrence of AF
(POSTAF(1)) and patients without recurrence of AF (POSTAF(–)). There were no significant differences
in ANP levels of each atrium between the two groups with time. Preop, just after induction of anesthesia;
POD, postoperative day.
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multiple atriotomy incisions and excision of both
atrial auricles. AF recurred transiently in 32% of
our patients, similar to rates in other reports.3, 4, 6
A comparison of patients with transient postop-
erative recurrence of AF with those without re-
currence showed that postoperative ANP levels in
the AF recurrence group did not increase signif-
icantly despite the AF, and there was no signifi-
cant difference in the ANP levels between the two
groups with time. Data from our study suggest
that decreased ANP levels after the CMP may
result from the multiple atriotomy incisions and
excision of both atrial auricles, rather than from
the conversion of AF to normal sinus rhythm.
Limitations. Several limitations of our study
must be recognized. First, there is no accepted
world standard for measuring human ANP.20 Nor-
mal levels of immunoreactive ANP are hard to
define, not only because of the lack of assay
standardization but also because the condition of
subjects in whom normal values are measured
varies within and between studied populations.
Factors such as the sodium-volume status, sys-
temic blood pressure, posture, age, heart and
renal function, and time of sampling all affect the
measurement. Second, the perioperative mea-
surement of hemodynamic parameters and blood
sampling for the ANP levels were not performed
under uniform conditions. Measurements obtained
before the operation were performed with pa-
tients under general anesthesia, whereas those
obtained after the operation were performed with
patients in an awake state. This may make it more
difficult to interpret the significance of changes in
various hemodynamic parameters and ANP levels.
Third, the CABG group was used as a control
group to compare the postoperative changes in
ANP levels. Taking into consideration the multi-
ple factors that may affect ANP levels, a non-CMP
group with valvular heart disease and chronic AF
would have been more suitable as a control group,
but such a group would have been extremely
difficult to incorporate into the study. Fourth, the
comparison of patients with transient recurrence
of AF with those without recurrence of AF used a
small sample size for each group, which may
preclude valid statistical comparison of the effect
of recurrence of AF on changes in ANP levels.
Conclusions
Despite several limitations in our study as a clinical
approach, we demonstrated a statistically significant
decrease in the ANP levels of both atria after the
CMP. This may be one of the causes of postoperative
fluid retention. This decrease in ANP levels after the
CMP may result from the multiple atriotomy incisions
and excision of both atrial auricles, rather than from
the conversion of AF to normal sinus rhythm.
Fig. 4. Changes in the RA ANP levels (RAANP) and RA pressures (RAP) in the CABG group. There
were insignificant changes in the RAANP and RAP after the operation. Preop, just after induction of
anesthesia; POD, postoperative day.
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Discussion
Dr. Tirone E. David (Toronto, Ontario, Canada). Not all
patients retain fluid after the CMP. In our experience,
which is limited to about 40 cases, I would say that fewer
than one in five require long-term diuretic therapy. They
do retain fluid for the first 2 or 3 days, but every patient
undergoing cardiopulmonary bypass does so. So there
must be factors other than the ANP. Do you think that
ANP is perhaps just one of several factors? Are there not
more factors that may play a role on this problem of fluid
retention?
Dr. Kim. Postoperative fluid retention with pulmonary
edema has been observed as one of the early postopera-
tive complications after the CMP in 12% to 36% of the
patients. This incidence is higher than that among the
other patients undergoing cardiopulmonary bypass. In our
study, we demonstrated a significant decrease in the ANP
levels after the CMP. These suggest that the decreased
ANP levels after the CMP may play an important role in
the problem of further fluid retention. Fortunately, the
patients in our study did not have any significant postop-
erative fluid retention despite the significant decrease in
the ANP levels. We believe this is because of preoperative
treatment with diuretics in response to some degree of
congestive heart failure and postoperative treatment with
diuretics to maintain adequate urine output.
Dr. Yoshio Kosakai (Osaka, Japan). We have done the
CMP on 270 patients from February 1992 to February
1997. Research similar to yours was performed by our
colleague, Dr. Yoshibara. In our results, the ANP value in
the CMP group did not increase after the operation. This
result was almost the same as yours. However, the ANP
value in our control group increased after the operation,
because the atrial appendages of the control group were
not removed. I think that our result is more reasonable
than yours. My question is, what do you think about this
difference?
Dr. Kim. Do you mean that the ANP levels in your
control group are higher than those in ours?
Dr. Kosakai. Yes, the ANP of our control group
increased more after operation than in your results.
Dr. Kim. Did you have the same control group as ours?
Dr. Kosakai. No. All diagnoses in our control group
were valvular disease.
Dr. Kim. In our CABG group, the ANP levels in the
RA showed no change after the operation. This finding is
a little different from those of others, including yours. As
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I indicated in my limitations, there are a couple of possible
explanations for this difference. First, there is no accepted
world standard for measuring human ANP. Second, a
CABG group with relatively small sample size was used as
a control group, and this may preclude valid statistical
comparison.
Dr. David. Your control group consisted solely of
patients undergoing CABG?
Dr. Kim. Yes.
Dr. David. You did not have patients undergoing
valvular procedures with similar problems?
Dr. Kim. No. Most of our patients undergoing valvular
procedures have AF, and I am doing the CMP in all the
patients with valvular heart disease with chronic AF,
thromboembolic events, or LA thrombus because the
CMP can cure chronic AF. So it was extremely difficult to
use a non-CMP group with valvular heart disease and
chronic AF as a control group.
Dr. Chi-Ming Wei (Baltimore, Md.). What kind of
mechanism do you think decreases ANP? Did you also
measure coronary sinus concentrations of ANP and com-
pare aortic position for ANP? In your slides, you show
that the decreases in both RA and LA concentrations of
ANP differ somewhat from the degree of ANP plasma
concentration.
Did you also measure another natriuretic peptide, such
as a brain natriuretic peptide? We know that the brain
natriuretic peptide is important for the cardiac release of
a natriuretic peptide hormone and is also an important
contributor to fluid balance.
Dr. Kim. In answer to your first question, we did not
measure the ANP levels in coronary sinus or aortic
positions. We measured the ANP levels in the RA and the
radial artery. The RA preoperative ANP levels were about
two times higher than those in the LA or radial artery,
reflecting secretion of ANP into the coronary sinus and
extraction by the lungs. We suggest that the decreased
ANP levels after the CMP may result from the multiple
atriotomy incisions and excision of both atrial auricles. In
response to the second question, we did not measure the
brain natriuretic peptide level.
Dr. Akira T. Kawaguchi (Kanagawa, Japan). I have
been wondering about the relationship between decrease
in ANP and the denervation of the heart that occurs after
the CMP. I also wonder whether you see the ANP level
come back up as the heart becomes innervated again. I
would like to know the relationship between denervation
and innervation of the heart and the level of ANP.
Dr. Kim. Fujiwara and associates,9 in the Journal of the
American College of Cardiology, showed a gradual increase
in the ANP levels in patients with AF from the fourth
hour to 5 days after cardioversion, concomitant with an
increase in LA filling fraction. In our study, the ANP
levels in the radial artery remained decreased until the
seventh postoperative day. We are not sure when the ANP
levels return to normal. However, if we follow the sugges-
tion of Fujiwara and associates, recovery of ANP secretion
after the CMP would be expected to be delayed more than
after the cardioversion, because we observed the restora-
tion of the LA function a few months after the operation
in most of our patients.
Dr. David. Dr. Cox, would you care to comment on the
importance of this hormone in fluid retention. What is the
proportion of patients that retain fluid?
Dr. James L. Cox (St. Louis, Mo.). Our results are a bit
different, although I have never reported them because I
am not sure that I can make any sense out of them. Our
actual numbers correlate more with Dr. Kosakai’s, in that
the ANP levels are elevated on the first postoperative day.
By the second or third day after the operation, they are
back to control levels. Thereafter they go down, but not as
dramatically as in this series.
Having said that, the standard errors of these numbers
are similar, in that if you plot each individual result it
looks like a scattergram. I think one problem is perhaps in
sampling. One of Dr. Kim’s initial statements was that
there is no worldwide standard for measuring ANP levels,
and I believe that this is a key to the confusion of results.
Some of the samples are taken from the radial artery,
some from the RA, some from the LA, and so on. Dr. Kim
is to be congratulated for his efforts to systematizing
sampling in the hope of obtaining more meaningful
results.
What we do know is that these patients do retain fluid
more aggressively after the operation than do patients
undergoing CABG or valvular procedures. They are more
comparable with the patients we used to operate on years
ago who had severe mitral stenosis and retained a lot of
fluid after the operation. Whether the tendency toward
excessive fluid retention after the CMP is a problem with
ANP, some alteration in the renin-angiotensin system, or
a problem with denervation of the heart, I do not know.
However, because of this tendency, we started routine use
of spironolactone.
I would advise surgeons who are doing this procedure
to be aggressive about putting these patients on some
regimen to reverse their tendency to retain fluid. I gener-
ally leave patients on regimen of spironolactone for 6
weeks and handle additional diuretic needs with furo-
semide (Lasix).
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